Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
At NINGBO INNO PHARMCHEM CO.,LTD., we are deeply invested in the progress of pharmaceutical science, particularly in the critical field of oncology. The development of effective anti-tumor agents relies heavily on the availability of high-purity chemical building blocks, and our compound, 4-Chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine (CAS 941685-26-3), plays a pivotal role.
This specific pyrrolo[2,3-d]pyrimidine derivative is a cornerstone in the synthesis pathway of Ruxolitinib. Ruxolitinib is a targeted therapy that has revolutionized the treatment of certain myeloproliferative neoplasms, demonstrating the profound impact that precise chemical synthesis can have on patient outcomes. The production of such life-saving medications necessitates intermediates that are not only pure but also consistently available.
Our commitment to chemical synthesis extends to ensuring that every batch of 4-Chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine meets stringent quality specifications. This dedication is vital for our clients, who are developing novel therapies and require dependable starting materials for their API synthesis processes. The reliability of a pharmaceutical intermediate directly influences the efficiency of the overall manufacturing process and the final quality of the drug.
As the landscape of drug discovery evolves, so does the demand for specialized chemical compounds. NINGBO INNO PHARMCHEM CO.,LTD. continuously monitors industry trends and scientific advancements to provide researchers and manufacturers with the essential chemical building blocks they need. The precise molecular structure of this intermediate, C12H18ClN3OSi, is engineered for optimal reactivity and incorporation into larger therapeutic molecules.
We understand that the journey from a chemical intermediate to a finished pharmaceutical product is complex. Therefore, we strive to be more than just a supplier; we aim to be a collaborative partner. By offering competitive pricing and reliable service for our Ruxolitinib intermediate and other fine chemicals, we empower our clients to focus on innovation and bringing life-changing treatments to market.
Choosing the right supplier for your pharmaceutical intermediate needs is a critical decision. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing unparalleled quality and service, ensuring that your research and development efforts are supported by the best possible chemical materials. We are proud to contribute to advancements in oncology treatment through the supply of such vital compounds.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
